Teclison Was Founded With The Vision Of Assembling Leading Scientistsadvisorsand Other Leaders With Significant Pharmaceutical Expertise To Develop Groundbreaking Therapies For Cancer The Company Specializes In The Development Of Innovative Cancer Medicines Which Induce Tumor Necrosis And Enhance Anti Tumor Immunity For Long Term Cancer Remission The Company S Drug Is Designed To Treat Any Solid Tumor With A Predilection For Liver Metastasisincluding Hepatocellular Carcinoma And Metastatic Colorectal Cancer Firstand Expanding To Other Solid Tumors With Liver Metastasisteclison S Novel Approach Is A First In Class Hypoxia Activating Agent Which Achieves Long Term Remission In Hard To Treat Cancer Cellcancer Stem Cells And Tumor Promoting Macrophage Targets By Creating High Local Concentration Of Its Compound And Producing Profound Hypoxia Exclusively Within The Tumor
United States
